CN103719997A - Guava leaf solid beverage - Google Patents
Guava leaf solid beverage Download PDFInfo
- Publication number
- CN103719997A CN103719997A CN201410006209.9A CN201410006209A CN103719997A CN 103719997 A CN103719997 A CN 103719997A CN 201410006209 A CN201410006209 A CN 201410006209A CN 103719997 A CN103719997 A CN 103719997A
- Authority
- CN
- China
- Prior art keywords
- guava leaf
- raw material
- solid beverage
- xylitol
- chinese yam
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 241000508269 Psidium Species 0.000 title claims abstract description 60
- 239000007787 solid Substances 0.000 title claims abstract description 29
- 235000013361 beverage Nutrition 0.000 title claims abstract description 28
- 235000002722 Dioscorea batatas Nutrition 0.000 claims abstract description 26
- 235000006536 Dioscorea esculenta Nutrition 0.000 claims abstract description 26
- 240000001811 Dioscorea oppositifolia Species 0.000 claims abstract description 26
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 claims abstract description 26
- 238000001914 filtration Methods 0.000 claims abstract description 26
- 239000002994 raw material Substances 0.000 claims abstract description 25
- 241000209020 Cornus Species 0.000 claims abstract description 23
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims abstract description 21
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims abstract description 21
- 239000000811 xylitol Substances 0.000 claims abstract description 21
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims abstract description 21
- 229960002675 xylitol Drugs 0.000 claims abstract description 21
- 235000010447 xylitol Nutrition 0.000 claims abstract description 21
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 claims abstract description 15
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 claims abstract description 15
- 239000000706 filtrate Substances 0.000 claims abstract description 7
- 238000001694 spray drying Methods 0.000 claims abstract description 4
- 244000241838 Lycium barbarum Species 0.000 claims description 24
- 239000009636 Huang Qi Substances 0.000 claims description 23
- 235000015459 Lycium barbarum Nutrition 0.000 claims description 22
- 235000013399 edible fruits Nutrition 0.000 claims description 22
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims description 14
- 239000007788 liquid Substances 0.000 claims description 14
- 239000000843 powder Substances 0.000 claims description 12
- 239000000463 material Substances 0.000 claims description 5
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 claims description 4
- 238000005516 engineering process Methods 0.000 claims description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 4
- 239000012141 concentrate Substances 0.000 claims description 3
- 238000007667 floating Methods 0.000 claims description 3
- 239000012634 fragment Substances 0.000 claims description 3
- 239000012535 impurity Substances 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 claims description 3
- 239000000203 mixture Substances 0.000 claims description 3
- 230000001954 sterilising effect Effects 0.000 claims description 3
- 238000005507 spraying Methods 0.000 claims 2
- 238000010237 hybrid technique Methods 0.000 claims 1
- 210000002784 stomach Anatomy 0.000 abstract description 18
- 210000003734 kidney Anatomy 0.000 abstract description 14
- 210000000952 spleen Anatomy 0.000 abstract description 12
- 239000008280 blood Substances 0.000 abstract description 11
- 210000004369 blood Anatomy 0.000 abstract description 11
- 238000000034 method Methods 0.000 abstract description 10
- 230000008569 process Effects 0.000 abstract description 4
- 230000000638 stimulation Effects 0.000 abstract description 4
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 abstract 1
- 241001106041 Lycium Species 0.000 abstract 1
- 229940107666 astragalus root Drugs 0.000 abstract 1
- 210000001035 gastrointestinal tract Anatomy 0.000 abstract 1
- 238000007781 pre-processing Methods 0.000 abstract 1
- 239000000600 sorbitol Substances 0.000 abstract 1
- 235000013616 tea Nutrition 0.000 description 11
- 241000699666 Mus <mouse, genus> Species 0.000 description 10
- 239000003814 drug Substances 0.000 description 9
- 230000000694 effects Effects 0.000 description 8
- 230000002218 hypoglycaemic effect Effects 0.000 description 8
- 230000007774 longterm Effects 0.000 description 8
- 238000012360 testing method Methods 0.000 description 8
- 230000006870 function Effects 0.000 description 7
- 239000004480 active ingredient Substances 0.000 description 6
- 230000035622 drinking Effects 0.000 description 6
- 210000002700 urine Anatomy 0.000 description 6
- 206010012601 diabetes mellitus Diseases 0.000 description 5
- 210000004185 liver Anatomy 0.000 description 5
- 210000001835 viscera Anatomy 0.000 description 5
- 230000006378 damage Effects 0.000 description 4
- 230000001105 regulatory effect Effects 0.000 description 4
- 206010012735 Diarrhoea Diseases 0.000 description 3
- 206010020772 Hypertension Diseases 0.000 description 3
- 241001122767 Theaceae Species 0.000 description 3
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 3
- 229930003944 flavone Natural products 0.000 description 3
- 235000011949 flavones Nutrition 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 210000000936 intestine Anatomy 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 210000003462 vein Anatomy 0.000 description 3
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 3
- 208000004232 Enteritis Diseases 0.000 description 2
- 235000015468 Lycium chinense Nutrition 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000000857 drug effect Effects 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 150000002212 flavone derivatives Chemical class 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 239000002398 materia medica Substances 0.000 description 2
- 230000007170 pathology Effects 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- SPFMQWBKVUQXJV-BTVCFUMJSA-N (2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanal;hydrate Chemical compound O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O SPFMQWBKVUQXJV-BTVCFUMJSA-N 0.000 description 1
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 206010001580 Albuminuria Diseases 0.000 description 1
- 244000144730 Amygdalus persica Species 0.000 description 1
- 208000037157 Azotemia Diseases 0.000 description 1
- 208000002249 Diabetes Complications Diseases 0.000 description 1
- 208000007342 Diabetic Nephropathies Diseases 0.000 description 1
- 206010012655 Diabetic complications Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 239000001263 FEMA 3042 Substances 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 description 1
- 235000006040 Prunus persica var persica Nutrition 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 208000001647 Renal Insufficiency Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001139 anti-pruritic effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 239000003908 antipruritic agent Substances 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 230000003139 buffering effect Effects 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 229960000673 dextrose monohydrate Drugs 0.000 description 1
- 208000033679 diabetic kidney disease Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- -1 flavone compound Chemical class 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 229960001031 glucose Drugs 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 201000006370 kidney failure Diseases 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 235000012680 lutein Nutrition 0.000 description 1
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 description 1
- 229960005375 lutein Drugs 0.000 description 1
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 description 1
- 239000001656 lutein Substances 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 210000000214 mouth Anatomy 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 201000001474 proteinuria Diseases 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229920002258 tannic acid Polymers 0.000 description 1
- LRBQNJMCXXYXIU-NRMVVENXSA-N tannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-NRMVVENXSA-N 0.000 description 1
- 229940033123 tannic acid Drugs 0.000 description 1
- 235000015523 tannic acid Nutrition 0.000 description 1
- 235000019640 taste Nutrition 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 208000009852 uremia Diseases 0.000 description 1
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/02—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation containing fruit or vegetable juices
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/385—Concentrates of non-alcoholic beverages
- A23L2/39—Dry compositions
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/70—Clarifying or fining of non-alcoholic beverages; Removing unwanted matter
- A23L2/72—Clarifying or fining of non-alcoholic beverages; Removing unwanted matter by filtration
- A23L2/74—Clarifying or fining of non-alcoholic beverages; Removing unwanted matter by filtration using membranes, e.g. osmosis, ultrafiltration
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
- A23L29/37—Sugar alcohols
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Water Supply & Treatment (AREA)
- Molecular Biology (AREA)
- Mycology (AREA)
- Medicines Containing Plant Substances (AREA)
- Non-Alcoholic Beverages (AREA)
Abstract
The invention discloses guava leaf solid beverage, which is prepared from the raw materials by the processes of preprocessing, decocting, filtering, merging filtrates, concentrating an obtained mixed filtrate, spray-drying and mixing. The guava leaf solid beverage comprises the following raw materials by weight: 6000-7500g of guava leaves, 1000-1500g of astragalus root, 3500-4000g of Chinese yam, 5500-6500g of lycium barbarm, 1600-2000g of pulp of cornus, 3000-45000g of radix rehmanniae preparata, 1000-2000g of maltose, 3600-4800g of xylitol and 450-550g of sorbitol. The guava leaf solid beverage disclosed by the invention can significantly reduce the blood sugar content, and also can play the roles of adjusting the spleen and the stomach and protecting kidneys after being drunk for a long period of time. In addition, the beverage can effectively avoid stimulation of effective components to gastrointestinal tracts after being drunk for a long period of time or drunk on an empty stomach.
Description
Technical field
The present invention relates to a kind of Guava Leaf solid beverage, belong to teas drink field.
Background technology
Guava Leaf has another name called chicken and vows tea, and bar in kind peach leaf, fiber crops, that pulls out leaf, pulls out the young heart, the guava heart etc., is dry leaf and the tender stem of band leaf of guava, gathers in spring, summer, dries or using fresh herb.Guava Leaf is square circle shape ellipse to oval, and many shrinkages are curling or broken, long 5 ~ 12cm, wide 3 ~ 5cm, tip circle or short point, base portion is blunt to circular, the full edge in edge, the light brown brown of upper surface, without hair, lower surface taupe brown, close by pubescence, master pulse and lateral vein all swell, and lateral vein is linked to be limit arteries and veins at nearly leaf margin place; Long 3 ~ the 6cm of petiole, keratin and crisp, frangibility; Flat four prismatics of tender stem, close by pubescence, gas delicate fragrance, puckery, micro-sweetness and bitterness.The custom of the fresh leaf treatment of America natives and the useful guava of the masses of Yunnan Blang enteritis, dysentery.Tender leaf, the bud tea making of guava for Japan, is used for the treatment of diabetes, hypertension, good effect and safely, have no side effect.The traditional Chinese medical science is thought: Guava Leaf is flat, sweet-puckery flavor, enters spleen, stomach, large intestine, Liver Channel, have promote the production of body fluid to quench thirst, relieving restlessness, astringing to arrest diarrhea, anti-inflammation hemostasia, the function such as antipruritic, often drinking can be clearing heat and detoxicating, prevents and treats enteritis and diarrhoea.
Modern pharmacology research proves, in Guava Leaf, contain flavone compound, can, by improving human body surrounding tissue to sugared utilization (CN102920785A) or by promoting the combination of single-minded acceptor on insulin and target cell membrane to adjust the metabolism (CN102217686A) of sugar, fat, there is effect hypoglycemic, antibacterial, antiviral, promoting blood circulation and removing blood stasis.At present, to Guava Leaf main application approach be to extract the active ingredient general flavone (CN 10292078A, CN 101703577A, CN1810797) of Guava Leaf to be applied to clinical treatment or to be configured to Chinese and Western medicine as medicinal active ingredient, oral or injection arrives result for the treatment of; Or utilize the extract of Guava Leaf and other batchings to be configured to tea-drinking long-term drinking (CN102217686A).
But the course of disease of diabetes is long and complicated, although injection or oral extractive of general flavone/medicament can be treated diabetes and hypertension, hyperlipidemia complication, need to undertakes heavy financial burden and patient and can produce dependence and the resistance to the action of a drug to medicine.Diabetes are along with illness there will be diabetic complication conventionally, except hypertension and high fat of blood, comparatively serious to the harm of kidney, and existing renal failure or uremia occur when serious.Under normal circumstances, hypoglycemic medicine need to taken and just can effectively bring into play its drug effect before the meal, but because there is no protection and the buffering of food, active ingredient is directly left in stomach through throat, with intestines wall and coat of the stomach Long Term Contact; The drug effect of extract or medicament is more intense, and diabetes are again the therapeutic processes of a longer-term, and long-term medicine is treated the various internal organs to patient, and the injury of kidney, spleen, stomach and enteron aisle is very serious.
Summary of the invention
The object of the invention is provides a kind of Guava Leaf solid beverage for the deficiencies in the prior art, and take Guava Leaf as function of polysaccharide component, the natural materials such as the Radix Astragali of proportioning life simultaneously, Chinese yam, matrimony vine, dogwood fruit and cultivated land also carry out fine finishining; Falling the hypoglycemic function that simultaneously regulates health each several part, function of spleen and stomach regulating is also protected kidney; Can avoid drinking the active ingredient causing to GI stimulation on an empty stomach because of long-term simultaneously; Can also evade the shortcoming that natural plants curative effect is slow, mouthfeel is poor.
Based on above-mentioned opinion, the present invention is achieved in that
A kind of Guava Leaf solid beverage, composition of raw materials is:
The raw Radix Astragali 1000~1500g of Guava Leaf 6000~7500g
Matrimony vine 5500~6500g Chinese yam 3500~4000g
Dogwood fruit 1600~2000g cultivated land 3000~4500g
Maltose 1000~2000g xylitol 3600~4800g
D-sorbite 450~550g.
The present invention also provides a kind of production method of Guava Leaf solid beverage, comprises the following steps:
(1) pretreatment of raw material: by Guava Leaf, the raw Radix Astragali, Chinese yam, matrimony vine, dogwood fruit and cultivated land, remove impurity and the part of going mouldy, clean, dry, be broken into respectively the fragment that length is 3~5cm;
(2) decoction, coarse filtration: according to raw material proportioning, pretreated raw material is added respectively to 55~75 times of amounts of water, decoct each 15~25min 4~6 times; Above-mentioned each decoction liquor is carried out respectively to coarse filtration, adopt 100 orders, 200 orders, 300 orders and 400 mesh sieve thin,tough silk successively to filter, remove floating foreign material and leave and take filtrate acquisition coarse filtration liquid;
(3) merge coarse filtration liquid and carry out fine filtering: merging above-mentioned coarse filtration liquid and carry out fine filtering, is the miillpore filter of 0.45 μ m, 0.22 μ m by aperture successively, and operating pressure 0.3MPa, obtains fine filtering liquid;
(4) concentrated, freeze drying: it is 1 ± 0.01 that fine filtering liquid is concentrated into relative density in reduced pressure concentration tank, and concentrate is obtained to instant powder by spray drying technology;
(5) mix, pack: maltose, xylitol and D-sorbite were pulverized to 200~300 mesh sieve thin,tough silk and obtain fine powder, and maltose, xylitol and D-sorbite fine powder were mixed to sterilizing with the instant powder of step 4 gained, according to the dose package of every bag 5 ± 0.1g.
The Radix Astragali of the present invention, nature and flavor are sweet, return lung, spleen, liver, kidney channel, have to strengthen immunity of organisms, protect the liver, regulate blood sugar, coronary artery dilator, improve the effect of myocardial blood supply.And in < < Japan hanako materia medica > >, record " Chinese yam helps the five internal organs, strengthening the bones and muscles "; Be described as " Chinese yam energy kidney-nourishing gas, strengthening the spleen and stomach " to Chinese yam in < < Compendium of Materia Medica > >.In matrimony vine, contain abundant LBP-X, carotenoid, lutein and matrimony vine seed element, the increase significantly significant curative effect of body immunity, moistening lung, removing heat to brighten vision of tool.The Radix Astragali, Chinese yam and matrimony vine have complementary effect at the Spleen-stomach Prescriptions mask that regulates body.
Dogwood fruit of the present invention, for kidney deficiency and liver, contains abundant Fructus Corni tannic acid, and IDD tool is had significant therapeutic effect; Cultivated land, taste is sweet, tepor, enters liver kidney two warps, the enriching yin of can enriching blood, benefit lean marrow, the also significant enriching yin and nourishing kidney effect of tool.
Guava Leaf solid beverage of the present invention, Guava Leaf has the curative effect that effectively reduces blood sugar, and auxiliary material Chinese yam, matrimony vine and Radix Astragali reasonable compatibility both can reduce blood sugar, strengthened the immunocompetence of body and the ability of function of spleen and stomach regulating simultaneously; And dogwood fruit and cultivated land in raw material significantly improves the protection to human internal organ, especially kidney; Long-term drinking Guava Leaf solid beverage of the present invention; not only can reduce significantly blood-sugar content; all right function of spleen and stomach regulating, protection kidney, the reasonable compatibility of medicine is avoided because of long-term drinking or is drunk the active ingredient causing to GI stimulation and damage on an empty stomach when reaching hypoglycemic object.
Accompanying drawing explanation
Fig. 1: process chart of the present invention.
The specific embodiment
The present invention is further illustrated to use non-limiting embodiment below.
Embodiment 1:
Get Guava Leaf 6000g, raw Radix Astragali 1000g, matrimony vine 5500g, Chinese yam 3500g, dogwood fruit 1600g and cultivated land 3000g, remove impurity and the part of going mouldy, clean, dry, be broken into respectively the fragment that length is 3~5cm; Add respectively 55~75 times of amounts of water, in ceramic pan, decoct each 15~25min 4~6 times; Each decoction liquor is carried out respectively to coarse filtration, adopt 100 orders, 200 orders, 300 orders and 400 mesh sieve thin,tough silk successively to filter, remove floating foreign material and leave and take filtrate acquisition coarse filtration liquid; Merging coarse filtration liquid and carry out fine filtering, is the miillpore filter of 0.45 μ m, 0.22 μ m by aperture successively, and operating pressure 0.3MPa, obtains fine filtering liquid; It is 1 ± 0.01 that fine filtering liquid is concentrated into relative density in reduced pressure concentration tank, and concentrate is obtained to instant powder by spray drying technology; 1200g maltose, 3600g xylitol and 500g D-sorbite were pulverized to 200~300 mesh sieve thin,tough silk and obtained fine powder, maltose, xylitol and D-sorbite fine powder were mixed to sterilizing with instant powder, according to the dose package of every bag 5g.All operations were is all carried out with reference to standard GB/T 12695 < < drink enterprise GMP > >.
Embodiment 2:
Step and technique are identical with embodiment 1, and difference is that the raw material proportioning of Guava Leaf solid tea beverage is: Guava Leaf 7500g, raw Radix Astragali 1500g, Chinese yam 4000g, matrimony vine 6500g, dogwood fruit 2000g, cultivated land 4500g, xylitol 4800g.
Embodiment 3:
Step and technique are identical with embodiment 1, and difference is that the raw material proportioning of Guava Leaf solid tea beverage is: Guava Leaf 6000g, raw Radix Astragali 1500g, Chinese yam 4000g, matrimony vine 6500g, dogwood fruit 2000g, cultivated land 4500g, xylitol 3800g.
Embodiment 4:
Step and technique are identical with embodiment 1, and difference is that the raw material proportioning of Guava Leaf solid tea beverage is: Guava Leaf 7500g, raw Radix Astragali 1000g, Chinese yam 3500g, matrimony vine 5500g, dogwood fruit 1600g, cultivated land 3000g, xylitol 4200g.
Embodiment 5:
Step and technique are identical with embodiment 1, and difference is that the raw material proportioning of Guava Leaf solid tea beverage is: Guava Leaf 6500g, raw Radix Astragali 1200g, Chinese yam 3700g, matrimony vine 6000g, dogwood fruit 1700g, cultivated land 3500g, xylitol 4000g.
Embodiment 6:
Step and technique are identical with embodiment 1, and difference is that the raw material proportioning of Guava Leaf solid tea beverage is: Guava Leaf 7000g, raw Radix Astragali 1400g, Chinese yam 3700g, matrimony vine 6500g, dogwood fruit 1800g, cultivated land 4000g, xylitol 4000g.
Embodiment 7:
Step and technique are identical with embodiment 1, and difference is that the raw material proportioning of Guava Leaf solid tea beverage is: Guava Leaf 6500g, raw Radix Astragali 1300g, Chinese yam 3500g, matrimony vine 6500g, dogwood fruit 2000g, cultivated land 4000g, xylitol 4000g.
Contrast test:
Configure 6 groups of control group solid beverages, carry out contrast test with the beverage of embodiment of the present invention 1-7 gained: blank group mouse is not injected any tea product, control group and embodiment group respectively oral cavity are injected corresponding beverage (5g beverage are dissolved in 50ml water, every injected in mice amount is 10ml, and be 6:00 in early morning inject time).Every glucose that mouse 12:00 at noon every day lumbar injection 2ml concentration is 3mg/ml, normally throw something and feed and raise every day, observes mouse symptom in the process of throwing something and feeding; After gathering a mouse blood to carry out blood sugar test, collection mouse whole day 85-90 days every days of test, urine is carried out albuminuria detection, and after off-test in 90 days, mouse is carried out to anatomic observation organ disease situation.Result of the test is as shown in table 1: the mean value of the measurement result that wherein blood-sugar content and proteinuria level are 85-90 days:
Table 1: mouse check experiment result
Above-mentioned control group 1 formula is: Guava Leaf 6500g; Control group 2 formulas are matrimony vine 6500g, raw Radix Astragali 1300g, Chinese yam 3500g; Contrast 3 formulas are: dogwood fruit 2000g, cultivated land 4000g; Control group 4 formulas are: control group 1+ control group 2; The formula of control group 5 is: control group 1+ control group 3; The formula of control group 6 is: control group 2+ control group 3.
As shown in Table 1, control group mice is the in the situation that of continuous injectable dextrose monohydrate, and blood-sugar content and urine protein content are very high, and urine protein content is the important indicator of evaluating diabetic nephropathy, the renal function generation pathology of the high explanation of urine protein content mouse.And simple take Guava Leaf as control group 1, although can reduce significantly blood sugar and urine protein content, long-term empty stomach is drunk and has been caused stomach and intestines to receive infringement, and kidney and spleen also have enlargement situation to occur.And simple control group 2 and/or control group 3 beverages taken, although can protect stomach and intestine or spleen kidney, hypoglycemic effect is not good, because blood-sugar content occupies high, concurrent kidney, spleen, stomach enlargement symptom, occurs yet.The hypoglycemic effect of control group 4 and control group 5 beverages is slightly desirable, still, has mouse frequent diarrhoea or abdominal distension symptom of occurring after the 55-60d of test of 40-50%.And the solid beverage of embodiments of the invention 1-7; fall significantly the hypoglycemic while, also can effectively reduce the content of viscous albumen in urine, very obvious for the protection effect of internal organ; process of the test small mouse is acted normally, and does not also find that pathology appears in any internal organs after dissecting.
The above results explanation, solid tea beverage of the present invention, not only can effectively reduce blood sugar, has the health-care efficacy of function of spleen and stomach regulating, protection kidney simultaneously; The reasonable compatibility of medicine is avoided because of long-term drinking or is drunk the active ingredient causing to GI stimulation and damage on an empty stomach when reaching the object of hypoglycemic.
Above-mentioned example just, for explanation technical conceive of the present invention and technical characterstic, can not limit the scope of the invention with this.Equivalent transformation or modification that all essence according to the present invention is done, within all should being encompassed in protection scope of the present invention.
Claims (9)
1. a Guava Leaf solid beverage, is characterized in that, by the raw material of following weight proportion, through pretreatment of raw material, decoction, filtration, merging filtrate, concentrated filtrate, spraying, dry and hybrid technique obtains:
The raw Radix Astragali 1000~1500g of Guava Leaf 6000~7500g
Matrimony vine 5500~6500g Chinese yam 3500~4000g
Dogwood fruit 1600~2000g cultivated land 3000~4500g
Maltose 1000~2000g xylitol 3600~4800 g
D-sorbite 450~550g.
2. Guava Leaf solid beverage according to claim 1, is characterized in that, described raw material proportioning is:
The raw Radix Astragali 1000g of Guava Leaf 6000g
Matrimony vine 5500g Chinese yam 3500g
Dogwood fruit 1600g cultivated land 3000g
Maltose 1200g xylitol 3600g
D-sorbite 500g.
3. Guava Leaf solid beverage according to claim 1, is characterized in that, described raw material proportioning is:
The raw Radix Astragali 1500g of Guava Leaf 7500g
Matrimony vine 6500g Chinese yam 4000g
Dogwood fruit 2000g cultivated land 4500g
Maltose 1200g xylitol 4800g
D-sorbite 500g.
4. Guava Leaf solid beverage according to claim 1, is characterized in that, described raw material proportioning is:
The raw Radix Astragali 1500g of Guava Leaf 6000g
Matrimony vine 6500g Chinese yam 4000g
Dogwood fruit 2000g cultivated land 4500g
Maltose 1200g xylitol 3800g
D-sorbite 500g.
5. Guava Leaf solid beverage according to claim 1, is characterized in that, described raw material proportioning is:
The raw Radix Astragali 1000g of Guava Leaf 7500g
Matrimony vine 5500g Chinese yam 3500g
Dogwood fruit 1600g cultivated land 3000g
Maltose 1200g xylitol 4200g
D-sorbite 500g.
6. Guava Leaf solid beverage according to claim 1, is characterized in that, described raw material proportioning is:
The raw Radix Astragali 1200g of Guava Leaf 6500g
Matrimony vine 6000g Chinese yam 3700g
Dogwood fruit 1700g cultivated land 3500g
Maltose 1200g xylitol 4000g
D-sorbite 500g.
7. Guava Leaf solid beverage according to claim 1, is characterized in that, described raw material proportioning is:
The raw Radix Astragali 1400g of Guava Leaf 7000g
Matrimony vine 6500g Chinese yam 3700g
Dogwood fruit 1800g cultivated land 4000g
Maltose 1200g xylitol 4000g
D-sorbite 500g.
8. Guava Leaf solid beverage according to claim 1, is characterized in that, described raw material proportioning is:
The raw Radix Astragali 1300g of Guava Leaf 6500g
Matrimony vine 6500g Chinese yam 3500g
Dogwood fruit 2000g cultivated land 4000g
Maltose 1200g xylitol 4000g
D-sorbite 500g.
9. according to the production method of the Guava Leaf solid beverage described in claim 1-8 any one, it is characterized in that, comprise the steps:
(1) pretreatment of raw material: by Guava Leaf, the raw Radix Astragali, Chinese yam, matrimony vine, dogwood fruit and cultivated land, remove impurity and the part of going mouldy, clean, dry, be broken into respectively the fragment that length is 3~5cm;
(2) decoction, coarse filtration: according to raw material proportioning, pretreated raw material is added respectively to 55~75 times of amounts of water, decoct each 15~25min 4~6 times; Above-mentioned each decoction liquor is carried out respectively to coarse filtration, adopt 100 orders, 200 orders, 300 orders and 400 mesh sieve thin,tough silk successively to filter, remove floating foreign material and leave and take filtrate acquisition coarse filtration liquid;
(3) merge coarse filtration liquid and carry out fine filtering: merging above-mentioned coarse filtration liquid and carry out fine filtering, is the miillpore filter of 0.45 μ m, 0.22 μ m by aperture successively, and operating pressure 0.3MPa, obtains fine filtering liquid;
(4) concentrated, spraying is dried: it is 1 ± 0.01 that fine filtering liquid is concentrated into relative density in reduced pressure concentration tank, and concentrate is obtained to instant powder by spray drying technology;
(5) mix, pack: maltose, xylitol and D-sorbite were pulverized to 200~300 mesh sieve thin,tough silk and obtain fine powder, and gained fine powder was mixed to sterilizing with the instant powder of step 4 gained, according to the dose package of every bag 5 ± 0.1g.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410006209.9A CN103719997B (en) | 2014-01-07 | 2014-01-07 | A kind of guava solid beverage |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410006209.9A CN103719997B (en) | 2014-01-07 | 2014-01-07 | A kind of guava solid beverage |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103719997A true CN103719997A (en) | 2014-04-16 |
CN103719997B CN103719997B (en) | 2016-01-20 |
Family
ID=50444491
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410006209.9A Expired - Fee Related CN103719997B (en) | 2014-01-07 | 2014-01-07 | A kind of guava solid beverage |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103719997B (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104305460A (en) * | 2014-10-13 | 2015-01-28 | 王林林 | Making method of psidium guajava health crystal grains |
CN106581169A (en) * | 2016-12-14 | 2017-04-26 | 佛山科学技术学院 | Drying method of guava leaves |
CN107183466A (en) * | 2017-05-23 | 2017-09-22 | 安徽元麦凡康食品有限公司 | A kind of auxiliary hyperglycemic solid beverage |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101322757A (en) * | 2008-07-28 | 2008-12-17 | 北京润德康医药技术有限公司 | Medicament composition for treating diabetes and method for preparing the same |
WO2010005438A1 (en) * | 2008-07-10 | 2010-01-14 | Amerilab Technologies, Inc. | Method of treating migraine using guava |
CN102441090A (en) * | 2011-12-20 | 2012-05-09 | 辽宁兴海制药有限公司 | Immunoregulation oral liquid |
-
2014
- 2014-01-07 CN CN201410006209.9A patent/CN103719997B/en not_active Expired - Fee Related
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010005438A1 (en) * | 2008-07-10 | 2010-01-14 | Amerilab Technologies, Inc. | Method of treating migraine using guava |
CN101322757A (en) * | 2008-07-28 | 2008-12-17 | 北京润德康医药技术有限公司 | Medicament composition for treating diabetes and method for preparing the same |
CN102441090A (en) * | 2011-12-20 | 2012-05-09 | 辽宁兴海制药有限公司 | Immunoregulation oral liquid |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104305460A (en) * | 2014-10-13 | 2015-01-28 | 王林林 | Making method of psidium guajava health crystal grains |
CN106581169A (en) * | 2016-12-14 | 2017-04-26 | 佛山科学技术学院 | Drying method of guava leaves |
CN107183466A (en) * | 2017-05-23 | 2017-09-22 | 安徽元麦凡康食品有限公司 | A kind of auxiliary hyperglycemic solid beverage |
Also Published As
Publication number | Publication date |
---|---|
CN103719997B (en) | 2016-01-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103689296B (en) | Feed for ewe at later pregnancy and lactation period and preparation method thereof | |
CN101695376B (en) | Health-care food for preventing diabetes | |
CN102988638B (en) | Cyclocarya paliurus blood-lipid and blood-sugar reducing health-care tea and preparation method thereof | |
CN104351573A (en) | Mixed feed for treating cow hypogalactia and preparation method thereof | |
CN103734428A (en) | Glossy-privet-fruit health-care tea for improving immunity and preparation method of tea | |
CN103653148B (en) | Guava leaf liquid beverage | |
CN104082672B (en) | A kind of health-preserving porridge with effect of lowering blood sugar and preparation method thereof | |
CN104904964A (en) | Folium apocyni veneti health tea capable of decreasing sugar and lipid and preparation method thereof | |
CN105454576A (en) | Jasmine-flower-comprising assorted Chinese herbal tea and preparation method thereof | |
KR20130104692A (en) | Composition foranti-obesity using extract of crataegi fructus | |
CN103719495B (en) | A kind of great burdock achene hypoglycemic health protection tea and preparation method thereof | |
CN104472789A (en) | Fructus sophorae tea for loosening bowels to relieve constipation and preparation method of fructus sophorae tea | |
CN103719997B (en) | A kind of guava solid beverage | |
KR20140034620A (en) | Composition for preventing or treating diabetbes mellitus disease containing extract of plants | |
CN104304602A (en) | Pagoda tree fruit tea capable of softening blood vessels and preparation method thereof | |
CN104206595A (en) | Blood lipid and blood glucose reducing Chinese wolfberry root-bark health care tea and preparation method thereof | |
CN103478435B (en) | Chinese medicinal composition and feed for improving fertility rate of male breeding poultries and preparation method of composition and feed | |
CN105494781A (en) | Giant knotweed rhizome health care tea for reducing blood glucose and lowering blood lipid | |
CN104397282A (en) | Tranquilization and brain tonifying eleutherococcus senticosus healthare tea and preparation method thereof | |
CN101336965A (en) | Chinese prepared medicine for improving sugar tolerance and reducing blood sugar and preparation method thereof | |
KR101095834B1 (en) | Natural tea composition prescribed based on patient's physical constitution | |
CN107970368A (en) | A kind of houttuynia oral administration liquid for helping to give up smoking and preparation method thereof | |
CN107158245A (en) | A kind of pharmaceutical formulation and its medicament and preparation method for being used to treat diabetes | |
CN103689561A (en) | Health-preserving health food formula beneficial for reducing lipid and losing weight and preparation method thereof | |
CN103720808B (en) | A kind of composition and use thereof, preparation method with relieving constipation effect |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20160120 Termination date: 20200107 |